Financials
- Market Capitalization 84.75 M
- Employee 76
- Founded 2018
- CEO N/A
- Website www.acrivon.com
- Headquarter Massachusetts, United States
- FIGI BBG011RWR2Q4
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-1.19
ratio cours/chiffre d'affaires
464.04
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4054 | TELO Telomir Pharmaceuticals, Inc. - Common Stock | 1.24 USD | +0.81% | -0.80% | -3.88% | +5.08% | 85.28 M USD | ||
| 4055 | NRXS Neuraxis, Inc. Common Stock | 6.88 USD | -3.64% | -7.28% | -1.15% | +26.70% | 85.20 M USD | ||
| 4062 | RLYB Rallybio Corporation - Common Stock | 15.89 USD | +1.02% | +0.19% | -0.50% | +3431.11% | 84.19 M USD | ||
| 4086 | ENTX Entera Bio Ltd. - Ordinary Shares | 1.64 USD | -1.20% | -4.65% | +31.20% | -7.34% | 80.73 M USD |